The meeting will focus on recent advances in hypertension research and foster connections among experts in hypertension and its relationship to cardiac and kidney disease, stroke, obesity and genetics. AHA’s Hypertension Scientific Sessions is a collaborative effort between AHA’s Council on Hypertension and Council on the Kidney in Cardiovascular Disease.
Dr Jorg Taubel will be in attendance. Please reach out if you would like to meet with Dr Taubel at the event via our contact page.
Richmond Pharmacology Appoints John Hotti as Chief Technology Officer
April 22, 2026
Richmond Pharmacology is pleased to announce the appointment of John Hotti as Chief Technology Officer (CTO), strengthening the company’s leadership in technology-enabled clinical research.
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
.svg){kind=small}
.avif)
